The Waltham, Mass.-based company said that Cowen and Company will serve as its sales agent in the sale, but has not stated how many shares or other details of the offering yet.
The round will be an “at the market” offering through Cowen and Corindus said it may reimburse Cowen up to a maximum of $62,500 for expenses related to the offering, according to an SEC filing.
In May, Corindus saw shares fall after the robotic-surgery platform maker missed sales expectations on Wall Street with its first quarter 2018 earnings results.
On December 11-12,DeviceTalks West is taking over Orange County's medtech industry with one of the most anticipated conferences of the winter, bringing you the best and brightest minds in the industry.
Dr. Robert Greenberg, Executive Chairman, Alfred E. Mann Foundation
Gary Guthart, President and Chief Executive Officer, Intuitive Surgical
Reggie Groves, CEO, REVA Medical
Use code KEYNOTE to save an additional 10%.